Kory James Wentworth insider trades

Open-market stock purchases and sales by Kory James Wentworth, Chief Financial Officer at Entrada Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2018.

Recent trades

DateStockTradeValue
Sep 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$12.4K
Apr 1, 2026TRDA Entrada Therapeutics, IncSold$32.4K
Mar 10, 2026TRDA Entrada Therapeutics, IncSold$148K
Mar 9, 2026TRDA Entrada Therapeutics, IncSold$66.2K
Mar 4, 2026TRDA Entrada Therapeutics, IncSold$97.9K
Mar 3, 2026TRDA Entrada Therapeutics, IncSold (not open market)$67.2K
Mar 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$34.3K
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Nov 21, 2025TRDA Entrada Therapeutics, IncSold$88.9K

Companies traded

  • TRDA Entrada Therapeutics, Inc: 37 sales, last Sep 2, 2026
  • BLUE bluebird bio, Inc: 11 sales, last Aug 3, 2020

Get free alerts when Kory James Wentworth files a new trade →